Prudent use of NSAIDs in patients with COVID-19, Dengue, and Chikungunya

Abdul Kader Mohiuddin

doi:10.33545/26647591.2023.v5.i1a.42

Prudent use of NSAIDs in patients with COVID-19, Dengue, and Chikungunya

Author(s):

Abdul Kader Mohiuddin

Abstract:

NSAIDs are most common pharmacological options for pain management, although their use is questionable in many viral diseases like COVID-19, Dengue, and Chikungunya. Newer studies suggest to limit their use in such cases and also reinforces more careful considerations in patients with liver and kidney injuries or concurrent administration with other drugs/nutraceuticals such as antioxidants or SSRIs.

DOI: 10.33545/26647591.2023.v5.i1a.42

Pages: 01-03 | 347 Views 117 Downloads

Download (575KB)

How to cite this article:

Abdul Kader Mohiuddin. Prudent use of NSAIDs in patients with COVID-19, Dengue, and Chikungunya. Int. J. Pharm. Clin. Res. 2023;5(1):01-03. DOI: 10.33545/26647591.2023.v5.i1a.42

Vol. 5, Issue 1, Part A (2023)

Prudent use of NSAIDs in patients with COVID-19, Dengue, and Chikungunya

Related Links